Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deals
MASH innovator drug partnerships surge over $2.5 bn in 2024YTD: GlobalData
MASH drugs secured over $5.7 billion in total partnership deal value from 2018 to 2024YTD, where 2024YTD is already the top year…
Active cooperation among APAC pharma companies gaining traction: GlobalData
According to GlobalData’s Pharmaceutical Intelligence Center, from 2019 to 2023, 673 deals (strategic alliances) occurred among…
Healthcare industry reported 97 deals worth $38.1 billion in Feb 2024
Deal value increased by 977 per cent in February 2024, compared to February 2023
Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023
Healthcare industry reported 84 deals worth $38.6 billion, in Dec 2023
Deal value increased by 4.4 per cent in Dec 2023, compared to Dec 2022
Deal value decreased by 16 per cent in May 2023, compared to May 2022
The healthcare industry reported 125 VC deals worth $2.7 billion in May 2023, compared to the last 12-month average (May 2022 to…
Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio
Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…
Sun Pharma to acquire Concert Pharma
Under the terms of the merger agreement, Sun Pharma will promptly commence a tender offer to acquire all outstanding shares of…
Quantumzyme and BEC Chemicals collaborate for green chemistry development
The agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active…